Smoking triggers dormant lung cancer to grow aggressively
the ONA take:
According to a new study published in the journal Science, researchers from Cancer Research UK have found that after an initial genetic alteration causes lung cancer in a patient, the disease can lie dormant and go undetected for over 20 years before becoming aggressive when triggered by further genetic mutations.
The lung cancer begins to grow aggressively when genetic mutations occur in other areas of the tumor. Because the tumor now consists of various genetic mutations, targeted treatments can often have limited success.
A biopsy may only identify one particular genetic fault, so when a targeted treatment is used to treat lung cancer with that genetic mutation, another area of the tumor with a different genetic mutation can take over.
Those genetic faults that occur down the road are often caused by smoking, the study found. Once the tumors grew, a protein called APOBEC began to create various new genetic mutations. The researchers hope that their findings will help improve early detection of lung cancer. A new study called TRACERx will study lung cancers in hundreds of patients to observe how those cancers evolve over time.
Lung cancer can lie dormant for over 20 years before becoming aggressive when triggered.
Lung cancer - the leading cause of cancer death in the US - can lie hidden within the body for over 20 years before suddenly becoming a rapidly growing and aggressive disease, researchers have discovered.
A recent study, carried out by Cancer Research UK scientists and published in Science, reveals that after the initial genetic fault that causes cancer in the patient, the disease can remain dormant and undetected for a long period of time only to become aggressively active when triggered by additional new genetic mistakes.
- Cabozantinib Activates Innate Immune Response, Eliminating Prostate Cancer
- Shorter Treatment of Breast Cancer with Trastuzumab May Lead to Improved Results
- Risk of Second Cancers Increased in Hodgkin Lymphoma Survivors
- Directly Informing Patients of Breast Cancer Risk, Options Improves Follow-Up Screening
- Kidney Cancer Metastases in Lung May Hide Undiagnosed Primary Lung Cancer
- Early Palliative Care Reduced ICU Use in Patients With Advanced Cancer
- Ginger Extract Raises Antioxidant Levels in Patients Undergoing Chemotherapy
- Nurse Navigators Improve Physician Engagement in Pretreatment Discussions
- Novel Blood Test Detects Cancer, Locates Tumor Without Invasive Procedures
- Screening Increases Early Palliative Care, Reduces Aggressive EOL Measures
- Free Lung Cancer Screening Findings Support Continual Screenings in High-Risk Populations
- Parental Self-persuasion in Low-Income Groups Improves HPV Vaccination Rates
- Discharge Events Improved With Standardized Inpatient Palliative Care Consultation
- Shared Decision-making Visits Improved Comfort With Lung Cancer Screening Decisions
- Temozolomide With Radiotherapy for Glioblastoma Provides Some Survival Benefit in Elderly
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|